Hedge Fund - Wynnefield Capital

Lifecore Biomedical Inc. (LFCR) 

Holding History Records
No. Filing Period Value % of Portfolio Number of Shares Avg. Quarterly Share Price
1 2024 - Q2 (2024-06-30) $25,234,362 11.34% 4,918,979 $5.92
2 2024 - Q1 (2024-03-31) $26,144,024 10.38% 4,923,545 $7.15
3 2023 - Q4 (2023-12-31) $30,476,744 11.78% 4,923,545 $6.94
4 2023 - Q3 (2023-09-30) $37,148,147 17.04% 4,923,545 $9.14
5 2023 - Q2 (2023-06-30) $47,610,680 23.8% 4,923,545 $6.11
6 2023 - Q1 (2023-03-31) $18,586,382 12.03% 4,923,545 $5.57
7 2022 - Q4 (2022-12-31) $28,917,065 16.63% 4,462,510 $8.24
8 2022 - Q3 (2022-09-30) $31,411,000 16.56% 3,533,287 $10.17
9 2022 - Q2 (2022-06-30) $35,227,000 17.8% 3,533,287 $9.90
10 2022 - Q1 (2022-03-31) $40,915,000 15.61% 3,533,287 $11.14
11 2021 - Q4 (2021-12-31) $34,919,000 12.46% 3,145,887 $9.70
12 2021 - Q3 (2021-09-30) $29,005,000 15.66% 3,145,887 $10.88
13 2021 - Q2 (2021-06-30) $35,391,000 16.31% 3,145,887 $11.53
14 2021 - Q1 (2021-03-31) $30,651,000 15.27% 2,905,300 $11.24
15 2020 - Q4 (2020-12-31) $31,306,000 15.82% 2,885,300 $10.33
16 2020 - Q3 (2020-09-30) $27,948,000 17.39% 2,875,300 $9.52
17 2020 - Q2 (2020-06-30) $22,887,000 16.86% 2,875,300 $10.32
18 2020 - Q1 (2020-03-31) $24,943,000 23.65% 2,870,300 $10.41
19 2019 - Q4 (2019-12-31) $32,463,000 21.66% 2,870,300 $10.64
20 2019 - Q3 (2019-09-30) $31,200,000 16.6% 2,870,300 $10.89
21 2019 - Q2 (2019-06-30) $26,192,000 13.42% 2,795,300 $10.09
22 2019 - Q1 (2019-03-31) $33,590,000 15.95% 2,735,300 $12.21
23 2018 - Q4 (2018-12-31) $31,759,000 16.1% 2,682,400 $13.73
24 2018 - Q3 (2018-09-30) $38,627,000 16.11% 2,682,400 $13.83
25 2018 - Q2 (2018-06-30) $39,968,000 14.75% 2,682,400 $13.90
26 2018 - Q1 (2018-03-31) $35,005,000 12.17% 2,682,400 $13.14
27 2017 - Q4 (2017-12-31) $33,798,000 11.66% 2,682,400 $12.64
28 2017 - Q3 (2017-09-30) $34,737,000 12.42% 2,682,400 $13.18
29 2017 - Q2 (2017-06-30) $39,833,000 13.28% 2,682,400 $13.92
30 2017 - Q1 (2017-03-31) $32,188,000 11.79% 2,682,400 $12.66
31 2016 - Q4 (2016-12-31) $37,016,000 13.33% 2,682,400 $13.85
32 2016 - Q3 (2016-09-30) $35,970,000 12.03% 2,682,400 $12.11
33 2016 - Q2 (2016-06-30) $28,863,000 10.44% 2,682,400 $11.03
34 2016 - Q1 (2016-03-31) $28,165,000 11.06% 2,682,400 $10.98
35 2015 - Q4 (2015-12-31) $31,732,000 10.72% 2,682,400 $12.28
36 2015 - Q3 (2015-09-30) $31,101,000 12.45% 2,665,000 $13.25
37 2015 - Q2 (2015-06-30) $38,239,000 14.72% 2,650,000 $14.43
38 2015 - Q1 (2015-03-31) $36,967,000 16.33% 2,650,000 $13.82
39 2014 - Q4 (2014-12-31) $36,596,000 15.51% 2,650,000 $12.92
40 2014 - Q3 (2014-09-30) $30,039,000 13.89% 2,630,000 $12.48
41 2014 - Q2 (2014-06-30) $21,412,000 9.86% 1,714,400 $11.77
42 2014 - Q1 (2014-03-31) $19,132,000 9.34% 1,714,400 $10.97
43 2013 - Q4 (2013-12-31) $19,141,000 8.57% 1,637,986 $11.94
44 2013 - Q3 (2013-09-30) $19,156,000 7.22% 1,637,986 $13.95
45 2013 - Q2 (2013-06-30) $22,853,000 8.58% 1,802,801 $13.83
46 2013 - Q1 (2013-03-31) $27,344,000 9.31% 1,964,700 $11.79
47 2012 - Q4 (2012-12-31) $19,781,000 6.87% 2,172,260 $10.05
48 2012 - Q3 (2012-09-30) $24,057,000 8.77% 2,193,271 $9.37
49 2012 - Q1 (2012-03-31) $16,005,000 5.59% 2,568,271 $6.31
50 2011 - Q4 (2011-12-31) $14,156,000 5.48% 2,564,524 $5.63
51 2011 - Q3 (2011-09-30) $12,665,000 5.37% 2,497,924 $6.06
52 2011 - Q2 (2011-06-30) $12,930,000 4.75% 2,012,714 $6.05
53 2011 - Q1 (2011-03-31) $10,055,000 4.84% 1,587,500 $6.30
54 2010 - Q4 (2010-12-31) $7,365,000 3.61% 1,247,218 $6.21

The displayed share prices are average quarterly stock market prices.